Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Change in Accured Expenses (2019 - 2021)

Historic Change in Accured Expenses for Black Diamond Therapeutics (BDTX) over the last 3 years, with Q4 2021 value amounting to -$2.0 million.

  • Black Diamond Therapeutics' Change in Accured Expenses fell 15692.09% to -$2.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $8.7 million, marking a year-over-year increase of 857.21%. This contributed to the annual value of -$756000.0 for FY2024, which is 11919.76% down from last year.
  • Per Black Diamond Therapeutics' latest filing, its Change in Accured Expenses stood at -$2.0 million for Q4 2021, which was down 15692.09% from $3.3 million recorded in Q3 2021.
  • Black Diamond Therapeutics' Change in Accured Expenses' 5-year high stood at $4.5 million during Q2 2021, with a 5-year trough of -$2.0 million in Q4 2021.
  • Moreover, its 3-year median value for Change in Accured Expenses was $1.8 million (2020), whereas its average is $1.5 million.
  • Per our database at Business Quant, Black Diamond Therapeutics' Change in Accured Expenses skyrocketed by 280000.0% in 2020 and then tumbled by 15692.09% in 2021.
  • Over the past 3 years, Black Diamond Therapeutics' Change in Accured Expenses (Quarter) stood at $931000.0 in 2019, then surged by 273.25% to $3.5 million in 2020, then crashed by 156.92% to -$2.0 million in 2021.
  • Its Change in Accured Expenses was -$2.0 million in Q4 2021, compared to $3.3 million in Q3 2021 and $4.5 million in Q2 2021.